238 related articles for article (PubMed ID: 34351501)
21. Prolonged intervals during Mycobacterium tuberculosis subunit vaccine boosting contributes to eliciting immunity mediated by central memory-like T cells.
Bai C; He J; Niu H; Hu L; Luo Y; Liu X; Peng L; Zhu B
Tuberculosis (Edinb); 2018 May; 110():104-111. PubMed ID: 29779765
[TBL] [Abstract][Full Text] [Related]
22. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
[TBL] [Abstract][Full Text] [Related]
23. Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against
Ullah N; Hao L; Wu Y; Zhang Y; Lei Q; Banga Ndzouboukou JL; Lin X; Fan X
J Immunol Res; 2020; 2020():2083793. PubMed ID: 32953889
[TBL] [Abstract][Full Text] [Related]
24. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.
Chuang YM; Pinn ML; Karakousis PC; Hung CF
Front Cell Infect Microbiol; 2018; 8():31. PubMed ID: 29473022
[No Abstract] [Full Text] [Related]
25. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of Bacillus subtilis spores and monophosphoryl lipid A as adjuvants of protein-based mycobacterium tuberculosis-based vaccines: partial requirement for interleukin-17a for induction of protective immunity.
Esparza-Gonzalez SC; Troy AR; Izzo AA
Clin Vaccine Immunol; 2014 Apr; 21(4):501-8. PubMed ID: 24477855
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.
Teng X; Tian M; Li J; Tan S; Yuan X; Yu Q; Jing Y; Zhang Z; Yue T; Zhou L; Fan X
Hum Vaccin Immunother; 2015; 11(6):1456-64. PubMed ID: 25905680
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.
Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212
[TBL] [Abstract][Full Text] [Related]
29. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.
Elvang T; Christensen JP; Billeskov R; Thi Kim Thanh Hoang T; Holst P; Thomsen AR; Andersen P; Dietrich J
PLoS One; 2009; 4(4):e5139. PubMed ID: 19357780
[TBL] [Abstract][Full Text] [Related]
30. Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection.
Clemmensen HS; Knudsen NPH; Billeskov R; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Mortensen R
Front Immunol; 2020; 11():585359. PubMed ID: 33240275
[TBL] [Abstract][Full Text] [Related]
31. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
[TBL] [Abstract][Full Text] [Related]
32. Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis.
Derrick SC; Repique C; Snoy P; Yang AL; Morris S
Infect Immun; 2004 Mar; 72(3):1685-92. PubMed ID: 14977976
[TBL] [Abstract][Full Text] [Related]
33. IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection.
Behrends J; Renauld JC; Ehlers S; Hölscher C
PLoS One; 2013; 8(2):e57379. PubMed ID: 23460846
[TBL] [Abstract][Full Text] [Related]
34. Comparison of immunogenicity and vaccine efficacy between heat-shock proteins, HSP70 and GrpE, in the DnaK operon of Mycobacterium tuberculosis.
Kim WS; Kim JS; Kim HM; Kwon KW; Eum SY; Shin SJ
Sci Rep; 2018 Sep; 8(1):14411. PubMed ID: 30258084
[TBL] [Abstract][Full Text] [Related]
35. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Cho SN; Coler RN; Reed SG; Shin SJ
Vaccine; 2016 Apr; 34(19):2179-87. PubMed ID: 27005808
[TBL] [Abstract][Full Text] [Related]
37. Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells.
Lenz N; Schindler T; Kagina BM; Zhang JD; Lukindo T; Mpina M; Bang P; Kromann I; Hoff ST; Andersen P; Reither K; Churchyard GJ; Certa U; Daubenberger CA
Clin Vaccine Immunol; 2015 Jul; 22(7):688-96. PubMed ID: 25924764
[TBL] [Abstract][Full Text] [Related]
38. BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4⁺IL-17⁺TNF⁺IL-2⁺ T cells.
Cruz A; Torrado E; Carmona J; Fraga AG; Costa P; Rodrigues F; Appelberg R; Correia-Neves M; Cooper AM; Saraiva M; Pedrosa J; Castro AG
Vaccine; 2015 Jan; 33(1):85-91. PubMed ID: 25448107
[TBL] [Abstract][Full Text] [Related]
39. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
40. Toll like-receptor agonist Pam
Kennerknecht K; Noschka R; Löffler F; Wehrstedt S; Pedersen GK; Mayer D; Grieshober M; Christensen D; Stenger S
Med Microbiol Immunol; 2020 Apr; 209(2):163-176. PubMed ID: 32020284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]